State data from 2018 through 2022 shows prostate cancer is the leading cancer diagnosis in Cuyahoga County, yet 77% of cases ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

A 2-step decision analytic model consisting of a decision tree-informed Markov structure was used to estimate lifetime outcomes in older patients with prostate cancer. The P-score reclassifies a ...

Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple ...

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

Despite the clinical utility of biomarker testing in patients with prostate cancer, the tests are infrequently ordered, preventing optimized care. Despite guideline recommendations and the efficacy of ...

Prostate cancer is still among the most prevalent cancers of men globally, but timely detection is everything. Over recent years, medical professionals have been emphasizing the key role of a simple ...

Former Premier League goalkeeper Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom. The 56-year-old was diagnosed with the ...

The analysis – reported at the European Association of Urology (EAU) annual congress in London, UK – shows that it is "no ...

Germline testing can identify hereditary cancer, which leads to implications for family members, cascade testing for relatives, and starting surveillance and prevention measures: Genetic testing in ...

HRR mutations are commonly of germline origin, with several real world studies suggesting a 23-44% probability of an HRR ...